Cesca Therapeutics to Announce Fiscal Third Quarter 2017 Financial Results on May 11, 2017
May 04, 2017 12:48 ET
|
Cesca Therapeutics Inc.
RANCHO CORDOVA, Calif., May 04, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today...
Cesca to Exhibit at the 25th International Society for Cellular Therapy (ISCT) Annual Meeting
May 02, 2017 16:05 ET
|
Cesca Therapeutics Inc.
RANCHO CORDOVA, Calif., May 02, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today...
CESCA Therapeutics to Present at the 2017 International Symposium of Translational Medicine in Stem Cell Myocardial Repair
April 11, 2017 07:15 ET
|
Cesca Therapeutics Inc.
RANCHO CORDOVA, Calif., April 11, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (Nasdaq:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies,...
Cesca Therapeutics’ Management Delivers Keynote Speech at the 2017 Shenzhen International Precision Medicine Summit
April 07, 2017 15:38 ET
|
Cesca Therapeutics Inc.
RANCHO CORDOVA, Calif., April 07, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (Nasdaq:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies,...
Cesca Therapeutics Announces Senior Management Promotions
April 03, 2017 06:00 ET
|
Cesca Therapeutics Inc.
RANCHO CORDOVA, Calif., April 03, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (Nasdaq:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies,...
Cesca CLI Feasibility Study Published in Peer-Reviewed Journal
March 20, 2017 06:00 ET
|
Cesca Therapeutics Inc.
RANCHO CORDOVA, Calif., March 20, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies,...
Cesca Therapeutics Highlights Promising Data for the Treatment of Chronic Non-Healing Ulcers
March 15, 2017 06:00 ET
|
Cesca Therapeutics Inc.
RANCHO CORDOVA, Calif., March 15, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care autologous cell-based therapies,...
Cesca Therapeutics Announces Closing of $5 Million Revolving Line of Credit
March 13, 2017 06:00 ET
|
Cesca Therapeutics Inc.
RANCHO CORDOVA, Calif., March 13, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care autologous cell-based therapies,...
Cesca Therapeutics Strengthens Leadership Team and Board of Directors
February 28, 2017 06:00 ET
|
Cesca Therapeutics Inc.
Appoints Ms. Vivian Liu as Chief Operating Officer Elects Dr. Russell Medford to its board of directors RANCHO CORDOVA, Calif., Feb. 28, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc....
Cesca Therapeutics Reports Second Quarter Fiscal 2017 Financial Results and Provides Business Update
February 13, 2017 16:05 ET
|
Cesca Therapeutics Inc.
RANCHO CORDOVA, Calif., Feb. 13, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cellular processing and point-of-care autologous cell-based therapies,...